According to a recent meta-analysis of 25 studies with 439 animals, SBP was shown to reduce myocardial infarction area through an increase of vascular endothelial growth factor (VEGF) and microvessel count in CHD, indicating that SBP’s cardioprotective effects are largely due to promotion of angiogenesis (Zhang et al., 2017). The gene discussed is VEGFA; the disease is coronary artery disorder.